TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

被引：166

作者：

Bowen, D. ^{[1
]}

Groves, M. J. ^{[1
]}

Burnett, A. K. ^{[2
]}

Patel, Y. ^{[3
]}

Allen, C. ^{[3
]}

Green, C. ^{[3
]}

Gale, R. E. ^{[3
]}

Hills, R. ^{[2
]}

Linch, D. C. ^{[3
]}

机构：

[1] Univ Dundee, Div Pathol & Neurosci, Dundee, Scotland

[2] Cardiff Univ, Welsh Sch Med, Dept Haematol, Cardiff, S Glam, Wales

[3] UCL, Dept Haematol, London, England

来源：

LEUKEMIA | 2009年 / 23卷 / 01期

关键词：

DISTINCT; ADULTS; TRIAL; YOUNG; AML;

D O I：

10.1038/leu.2008.173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：203 / 206

页数：5

相关论文

共 8 条

[1] Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? [J].

Cornelissen, Jan J. ;

van Putten, Wim L. J. ;

Verdonck, Leo F. ;

Theobald, Matthias ;

Jacky, Emanuel ;

Daenen, Simon M. G. ;

Kooy, Marinus van Marwijk ;

Wijermans, Pierre ;

Schouten, Harry ;

Huijgens, Peter C. ;

van der Lelie, Hans ;

Fey, Martin ;

Ferrant, Augustin ;

Maertens, Johan ;

Gratwohl, Alois ;

Lowenberg, Bob .

BLOOD, 2007, 109 (09) :3658-3666

[2] The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia [J].

Gale, Rosemary E. ;

Green, Claire ;

Allen, Christopher ;

Mead, Adam J. ;

Burnett, Alan K. ;

Hils, Robert K. ;

Linch, David C. .

BLOOD, 2008, 111 (05) :2776-2784

[3] Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial [J].

Goldstone, AH ;

Burnett, AK ;

Wheatley, K ;

Smith, AG ;

Hutchinson, RM ;

Clark, RE .

BLOOD, 2001, 98 (05) :1302-1311

[4] Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10) [J].

Hann, IM ;

Stevens, RF ;

Goldstone, AH ;

Rees, JKH ;

Wheatley, K ;

Gray, RG ;

Burnett, AK .

BLOOD, 1997, 89 (07) :2311-2318

[5] FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia [J].

Mead, Adam J. ;

Linch, David C. ;

Hills, Robert K. ;

Wheatley, Keith ;

Burnett, Alan K. ;

Gale, Rosemary E. .

BLOOD, 2007, 110 (04) :1262-1270

[6] Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:: are we ready for a prognostically prioritized molecular classification? [J].

Mrozek, Krzysztof ;

Marcucci, Guido ;

Paschka, Peter ;

Whitman, Susan P. ;

Bloomfield, Clara D. .

BLOOD, 2007, 109 (02) :431-448

[7] Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia [J].

Pedersen-Bjergaard, J. ;

Christiansen, D. H. ;

Desta, F. ;

Andersen, M. K. .

LEUKEMIA, 2006, 20 (11) :1943-1949

[8] Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile [J].

Schoch, C ;

Kern, W ;

Kohlmann, A ;

Hiddemann, W ;

Schnittger, S ;

Haferlach, T .

GENES CHROMOSOMES & CANCER, 2005, 43 (03) :227-238